Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abeona Therapeutics Inc. - Common Stock
(NQ:
ABEO
)
5.070
-0.080 (-1.55%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
525,465
Open
5.150
Bid (Size)
5.000 (600)
Ask (Size)
5.090 (1,500)
Prev. Close
5.150
Today's Range
5.040 - 5.150
52wk Range
3.933 - 7.540
Shares Outstanding
54,191,361
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Keep an eye on the top gainers and losers in Wednesday's session.
↗
November 12, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 12, 2025
Via
Benzinga
Performance
YTD
-14.2%
-14.2%
1 Month
+5.4%
+5.4%
3 Month
-26.0%
-26.0%
6 Month
-19.3%
-19.3%
1 Year
-20.0%
-20.0%
More News
Read More
Here's Why Abeona Therapeutics Popped Higher Today
↗
November 12, 2025
Via
The Motley Fool
There are notable gap-ups and gap-downs in today's session.
↗
November 12, 2025
Via
Chartmill
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Abeona Therapeutics (NASDAQ:ABEO) Stock Falls on Revenue Miss Despite Q3 EPS Beat
↗
November 12, 2025
Via
Chartmill
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
November 12, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
What to Expect from Abeona Therapeutics's Earnings
↗
November 11, 2025
Via
Benzinga
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
November 07, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
October 30, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
October 20, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
October 13, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
October 08, 2025
From
Abeona Therapeutics Inc.; Children's Hospital of Colorado
Via
GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 16, 2025
Via
Benzinga
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
August 29, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Posts Q2 Profit on Asset Sale
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
August 14, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
AscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease Patients
July 29, 2025
From
AscellaHealth, LLC
Via
GlobeNewswire
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
July 15, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
July 02, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy
July 01, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Abeona Therapeutics Inc. - Common Stock publicly traded?
Yes, Abeona Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Abeona Therapeutics Inc. - Common Stock trade on?
Abeona Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Abeona Therapeutics Inc. - Common Stock?
The ticker symbol for Abeona Therapeutics Inc. - Common Stock is ABEO on the Nasdaq Stock Market
What is the current price of Abeona Therapeutics Inc. - Common Stock?
The current price of Abeona Therapeutics Inc. - Common Stock is 5.070
When was Abeona Therapeutics Inc. - Common Stock last traded?
The last trade of Abeona Therapeutics Inc. - Common Stock was at 11/28/25 01:00 PM ET
What is the market capitalization of Abeona Therapeutics Inc. - Common Stock?
The market capitalization of Abeona Therapeutics Inc. - Common Stock is 274.75M
How many shares of Abeona Therapeutics Inc. - Common Stock are outstanding?
Abeona Therapeutics Inc. - Common Stock has 275M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
